15 results
DEF 14A
CADL
Candel Therapeutics Inc
2 Sep 22
Definitive proxy
8:30am
related person transactions for potential conflict of interest situations and approving all such transactions; and
reviewing quarterly earnings … requirements. We do not believe the retention of, and the work performed by, Aon creates any conflict of interest because Aon performs no other work
8-K
EX-99.1
CADL
Candel Therapeutics Inc
6 Jun 22
Regulation FD Disclosure
8:37am
Medicine, and Director of the Multidisciplinary Pulmonary Oncology Program at NYU Langone Health Conflict of interest disclosure: Nothing to disclose 15 … of Medical Oncology at the Yale Cancer Center and Smilow Cancer Hospital Conflict of interest disclosure: Member of Candel’s Research Advisory Board
10-K
2021 FY
EX-10.12
CADL
Candel Therapeutics Inc
29 Mar 22
Annual report
8:46am
activities, and (ii) serve on boards of directors of companies that are not competitive with the Company, do not otherwise present a conflict of interest
424B4
CADL
Candel Therapeutics Inc
28 Jul 21
Prospectus supplement with pricing info
4:02pm
to compliance with applicable conflict of interest rules.
Our Strengths
We believe our experience and capabilities in oncolytic viral immunotherapy … for potential conflict of interest situations and approving all such transactions; and
reviewing quarterly earnings releases and scripts.
Compensation
S-1/A
EX-10.5.4
hpo 49mk4e2jwbg6x76
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-10.6
l5ly5ndi lxyy
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-10.5.3
7bpoon23pcxpew81arzi
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-10.5.5
qn842d1ia os9t3
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-10.5.2
qjf6n1to81 06g
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
wv8a3f5r6ohlhwr4s
16 Jul 21
IPO registration (amended)
6:07am
S-1
EX-4.2
xeom1snc0jg5
25 Jun 21
IPO registration
5:28pm
S-1
p1l6h
25 Jun 21
IPO registration
5:28pm
DRS/A
y1jw7djm oq79kfq7
31 Mar 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next